Combination of Anticholinergic Agent and H2 Receptor Antagonist in Duodenal Ulcer Treatment - A Randomized, Double Blind Multicenter Study

B K AGRAWAL; A SUMAN; A KUMAR; S L BROOR; P RAJASAMBANDAM; K R PALANISWAMY; A T MOHAN; J P GUPTA

首页> 外文期刊>Indian journal of gastroenterology >Combination of Anticholinergic Agent and H2 Receptor Antagonist in Duodenal Ulcer Treatment - A Randomized, Double Blind Multicenter Study

【24h】

Combination of Anticholinergic Agent and H2 Receptor Antagonist in Duodenal Ulcer Treatment - A Randomized, Double Blind Multicenter Study

机译：抗胆碱能药和H2受体拮抗剂联合治疗十二指肠溃疡-一项随机，双盲，多中心研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Indian journal of gastroenterology》 |1993年第july期|共3页
作者
B K AGRAWAL; A SUMAN; A KUMAR; S L BROOR; P RAJASAMBANDAM; K R PALANISWAMY; A T MOHAN; J P GUPTA;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Ilaprazole Compared With Rabeprazole in the Treatment of Duodenal Ulcer A Randomized, Double-blind, Active-controlled, Multicenter Study [J] . Li Fan, Qin Xianghong, Wang Ling, Journal of clinical gastroenterology . 2019,第9期

机译：Ilaprazole与Rabeprazole相比，治疗十二指肠溃疡A随机，双盲，主动控制，多中心研究
2. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial. [J] . Wang L, Zhou L, Lin S, Journal of clinical gastroenterology . 2011,第4期

机译：一种新的PPI ilaprazole与omeprazole相比在十二指肠溃疡的治疗中：一项随机的双盲多中心试验。
3. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: A Hoosier Oncology Group study [J] . AlbanyC., BramesM.J., FauselC., Journal of Clinical Oncology . 2012,第32期

机译：接受5天顺铂联合化疗方案的生殖细胞肿瘤患者中口服神经激肽1拮抗剂aprepitant联合5HT3受体拮抗剂和地塞米松的随机，双盲，安慰剂对照III期交叉研究肿瘤小组研究
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Development of a novel intragastric controlled release delivery system for simultaneous delivery of metronidazole, tetracycline hydrochloride, colloidal bismuth subcitrate and an H2 receptor antagonist: Used in eradication of Helicobacter pylori associated ulcer. [D] . Wu, Yunqi. 2004

机译：新型胃内控释输送系统的开发，用于同时输送甲硝唑，四环素盐酸盐，胶体次柠檬酸铋和H2受体拮抗剂：用于根除幽门螺杆菌相关溃疡。
6. PM308. A phase 3 multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction. [O] . E. Krupitsky, E. Mukhametshina, M. Samsonov 2016

机译：PM308。阿片类药物受体拮抗剂–Odelepran的3期多中心随机双盲安慰剂对照研究研究了酒精成瘾。
7. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial [O] . Stanley Cohen, Eric Hurd, John Cush, 2002

机译：用Anakina，一种重组人白细胞介素-1受体拮抗剂治疗类风湿性关节炎，与甲氨蝶呤组合：24周，多中心，随机，双盲，安慰剂对照试验的结果
8. Study to Determine the Changes of Physician Prescribing Patterns of AntimicrobialAgents, Omeprazole and H2-Receptor Antagonists for Peptic Ulcer Disease Two Years Following the NIH Consensus Conference on 'H. Pylori' [R] . Thamer, M., Ray, N. F., Henderson, S., 1997

机译：在美国国立卫生研究院共识会议之后两年，确定消化性溃疡病的抗菌药物，奥美拉唑和H2受体拮抗剂的医师处方模式变化的研究幽门螺杆菌”

Combination of Anticholinergic Agent and H2 Receptor Antagonist in Duodenal Ulcer Treatment - A Randomized, Double Blind Multicenter Study

著录项

相似文献

相关主题

期刊订阅